Current strategies for the treatment of CLL.
Montserrat
E
E
Postgraduate School of Hematology Farreras-Valenti, University of Barcelona, Spain.
Hallek
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000628:therapy*
D000970:Antineoplastic Agents; D016898:Interferon-alpha